Clinical Trial Update: Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of erlotinib, cisplatin, and radiation therapy for stage IB-IV cervical cancer; the study has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Cervical Cancer | Phase 1 | Status: WITHDRAWN